BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.
Molecular Weight:
453.53
Purity:
96.74%
CAS Number:
[2283349-24-4]
Formula:
C24H31N5O4
Target:
EGFR|||BTK
T73381
* VAT and and shipping costs not included. Errors and price changes excepted